Argenx
ARGX
#555
Rank
S$49.36 B
Marketcap
$784.53
Share price
2.91%
Change (1 day)
46.19%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of December 2024 : S$52.49 Million

According to Argenx 's latest financial reports the company's total debt is S$52.49 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2024-12-31S$53.08 M100.97%
2023-12-31S$26.41 M58.56%
2022-12-31S$16.65 M7.48%
2021-12-31S$15.49 M-1.36%
2020-12-31S$15.71 M42.16%
2019-12-31S$11.05 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31S$3.61 M-1.86%
2011-12-31S$3.68 M